Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
Camm
A John
AJ
Kirchhof
Paulus
P
Lip
Gregory Y H
GY
Schotten
Ulrich
U
Savelieva
Irene
I
Ernst
Sabine
S
Van Gelder
Isabelle C
IC
Al-Attar
Nawwar
N
Hindricks
Gerhard
G
Prendergast
Bernard
B
Heidbuchel
Hein
H
Alfieri
Ottavio
O
Angelini
Annalisa
A
Atar
Dan
D
Colonna
Paolo
P
De Caterina
Raffaele
R
De Sutter
Johan
J
Goette
Andreas
A
Gorenek
Bulent
B
Heldal
Magnus
M
Hohloser
Stefan H
SH
Kolh
Philippe
P
Le Heuzey
Jean-Yves
JY
Ponikowski
Piotr
P
Rutten
Frans H
FH
D054058:Acute Coronary Syndrome / Q000453:epidemiology / Q000628:therapy; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D056352:Athletes / Q000706:statistics & numerical data; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D002312:Cardiomyopathy, Hypertrophic / Q000453:epidemiology; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology; D004554:Electric Countershock / Q000295:instrumentation / Q000379:methods; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000453:epidemiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006349:Heart Valve Diseases / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006980:Hyperthyroidism / Q000453:epidemiology; D008171:Lung Diseases / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D015995:Prevalence; D014927:Wolff-Parkinson-White Syndrome / Q000453:epidemiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D010975:Platelet Aggregation Inhibitors